Metabolic disposition of pantoprazole, a proton pump inhibitor, in relation to S-mephenytoin 4'-hydroxylation phenotype and genotype (Q74058615)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9433390%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

title

Metabolic disposition of pantoprazole, a proton pump inhibitor, in relation to S-mephenytoin 4'-hydroxylation phenotype and genotype (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9433390%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

author name string

M Tanaka

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9433390%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

T Ohkubo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9433390%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

K Otani

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9433390%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

A Suzuki

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9433390%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

S Kaneko

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9433390%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

K Sugawara

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9433390%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Y Ryokawa

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9433390%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

H Hakusui

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9433390%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

S Yamamori

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9433390%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

T Ishizaki

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9433390%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

publication date

1 December 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9433390%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacology & Therapeutics

8 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9433390%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

volume

62

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9433390%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

page(s)

619-628

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9433390%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9433390%20AND%20SRC:MED&resulttype=core&format=json

By 1023/SK&F 96022: biochemistry of a novel (H+ + K+)-ATPase inhibitor

8 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990081-3

Pharmacokinetics of pantoprazole following single intravenous and oral administration to healthy male subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990081-3

Pantoprazole. A review of its pharmacological properties and therapeutic use in acid-related disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990081-3

Effect of omeprazole treatment on diazepam plasma levels in slow versus normal rapid metabolizers of omeprazole.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990081-3

Comparison of the kinetic disposition and metabolism of E3810, a new proton pump inhibitor, and omeprazole in relation to S-mephenytoin 4'-hydroxylation status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990081-3

Interphenotype differences in disposition and effect on gastrin levels of omeprazole--suitability of omeprazole as a probe for CYP2C19

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990081-3

The hydroxylation of omeprazole correlates with S-mephenytoin metabolism: a population study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990081-3

Pharmacokinetics of omeprazole (a substrate of CYP2C19) and comparison with two mutant alleles, C gamma P2C19m1 in exon 5 and C gamma P2C19m2 in exon 4, in Japanese subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990081-3

Metabolic disposition of lansoprazole in relation to the S-mephenytoin 4'-hydroxylation phenotype status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990081-3

Metoprolol and mephenytoin oxidation polymorphisms in Far Eastern Oriental subjects: Japanese versus mainland Chinese

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990081-3

Genetic analysis of the S-mephenytoin polymorphism in a Chinese population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990081-3

High-performance liquid chromatographic determination of the H+/K+ ATPase inhibitor (BY 1023/SK&F 96,022) and its sulphone metabolite in serum or plasma by direct injection and fully automated pre-column sample clean-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990081-3

Pharmacogenetics of mephenytoin: a new drug hydroxylation polymorphism in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990081-3

Mephenytoin hydroxylation deficiency in Caucasians: frequency of a new oxidative drug metabolism polymorphism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990081-3

Genetic polymorphism of S-mephenytoin hydroxylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990081-3

Genetic polymorphism of mephenytoin p(4')-hydroxylation: difference between Orientals and Caucasians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990081-3

Interethnic differences in genetic polymorphism of debrisoquin and mephenytoin hydroxylation between Japanese and Caucasian populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990081-3

Hydroxylation polymorphisms of debrisoquine and mephenytoin in European populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990081-3

Phenotyping polymorphic drug metabolism in the French Caucasian population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990081-3

Pharmacogenetic phenotyping and genotyping. Present status and future potential.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990081-3

Assessment of liver metabolic function. Clinical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990081-3

The role of S-mephenytoin 4'-hydroxylase in imipramine metabolism by human liver microsomes: a two-enzyme kinetic analysis of N-demethylation and 2-hydroxylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990081-3

Importance of genetic factors in the regulation of diazepam metabolism: relationship to S-mephenytoin, but not debrisoquin, hydroxylation phenotype.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990081-3

Incidence of S-mephenytoin hydroxylation deficiency in a Korean population and the interphenotypic differences in diazepam pharmacokinetics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990081-3

Isolation and characterization of human liver cytochrome P450 2C19: correlation between 2C19 and S-mephenytoin 4'-hydroxylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990081-3

Evidence that CYP2C19 is the major (S)-mephenytoin 4'-hydroxylase in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990081-3

Genotyping of S-mephenytoin 4'-hydroxylation in an extended Japanese population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990081-3

Identification of human liver cytochrome P450 isoforms mediating omeprazole metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990081-3

Identification of human liver cytochrome P450 isoforms mediating secondary omeprazole metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990081-3

Effect of repeated oral administration of BY 1023/SK&F 96022--a new substituted benzimidazole derivative--on pentagastrin-stimulated gastric acid secretion and pharmacokinetics in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990081-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Polymorphic hydroxylation of S-mephenytoin and omeprazole metabolism in Caucasian and Chinese subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990081-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0009-9236(97)90081-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9433390%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference